RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Procept Biorobotics Stock

Procept Biorobotics Employees 2024

Procept Biorobotics Employees

234

Ticker

PRCT

ISIN

US74276L1052

In 2024, Procept Biorobotics employed 234 people, a 0% change from the 234 number of employees in the previous year.

Procept Biorobotics Aktienanalyse

What does Procept Biorobotics do?

PROCEPT BioRobotics Corp (PROCEPT) is a California-based medical technology company specializing in the development of robotic technologies for urological surgery. History: PROCEPT was founded in 2013 by Dr. Chin and his group at Johns Hopkins University School of Medicine. They developed a novel technology that had the potential to revolutionize the treatment of prostate cancer. PROCEPT used a robust Intuitive Surgical platform and developed a novel tissue classification technology that allows surgeons to operate with accuracy and safety. The first system, called AquaBeam®, was approved by the US Food and Drug Administration (FDA) in 2018 and has since been in use in Europe and the US. Business: PROCEPT aims to improve urological surgery through the use of robotic technologies, thereby increasing patient safety and care. The company focuses on the development and commercialization of robotic systems for the treatment of prostate cancer and other urological diseases. Products: PROCEPT has developed Aquablation®, a robotic system for the treatment of prostate cancer. It is a minimally invasive technology that uses high-precision waterjet cutting (accuracy reduced to millimeters) to remove cancerous tissue quickly, effectively, and accurately. The technology can also be used in surgical procedures on the bladder, urethra, and other urological organs. Divisions: PROCEPT has a broad portfolio of services and products in the field of urological surgery. The AquaBeam® technology is the first system developed to treat malignant prostate tumors using robotic technologies. The technology is used in hospitals, clinics, and medical facilities worldwide. In addition, PROCEPT offers training and support for surgeons and medical personnel. Conclusion: PROCEPT BioRobotics Corp is an emerging medical technology company specializing in robotics-based urological surgery. The AquaBeam® technology is an innovative, robotic technology for the treatment of prostate cancer. The company is on its way to revolutionizing urological surgery and making a significant contribution to improving healthcare. Procept Biorobotics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Employees Details

Examining Procept Biorobotics's Employee Base

Procept Biorobotics's employees are a pivotal aspect of its operations, driving innovation, productivity, and growth. The size and composition of the workforce offer insights into the company's scale, diversity, and investment in human capital. Analyzing employee trends and data is essential for understanding Procept Biorobotics's operational capacity and future potential.

Year-to-Year Comparison

Assessing Procept Biorobotics's employee numbers year-over-year helps in identifying growth patterns, expansions, or contractions. An increasing employee count can indicate scaling operations and investment in talent, while a decrease may signal efficiency improvements, automation, or business challenges.

Impact on Investments

Procept Biorobotics's employee data impacts investment decisions by shedding light on the company’s operational efficiency, innovation capability, and sustainability. Investors assess workforce data to gauge the firm's potential to execute strategies, innovate, and adapt to market changes effectively.

Interpreting Employee Trends

Fluctuations in Procept Biorobotics’s employee numbers indicate changes in business strategy, operational demands, and market dynamics. Investors and analysts scrutinize these trends to evaluate the company’s strategic positioning, adaptability, and potential for sustainable growth.

Frequently Asked Questions about Procept Biorobotics stock

How many employees does Procept Biorobotics have this year?

Procept Biorobotics has 234 undefined employees this year.

How many employees did Procept Biorobotics have compared to the previous year?

Compared to the previous year, Procept Biorobotics had 0% more employees.

What impact did the number of employees have on the company Procept Biorobotics?

The number of employees has a direct impact on the efficiency and productivity of Procept Biorobotics. A higher number of employees can indicate that the company is growing and has more resources to achieve its goals, while a lower number of employees may suggest that the company is saving costs or facing difficulties in recruiting new employees.

What impact did the number of employees have on investors of Procept Biorobotics?

The number of employees can also have an impact on investors of Procept Biorobotics, as it can be an indicator of the company's growth and financial health. A higher number of employees can promise investors, while a lower number of employees may raise concerns.

How does an increase in equity capital of Procept Biorobotics affect the company?

An increase in equity of Procept Biorobotics can improve the financial strength of the company and increase its ability to make future investments and fulfill obligations.

How does a reduction in Procept Biorobotics's equity affect the company?

A reduction in equity of Procept Biorobotics can impair its financial stability and decrease its ability to fulfill future investments and obligations.

What are some factors that influence the equity of Procept Biorobotics?

Some factors that can influence the equity of Procept Biorobotics include, among others, revenue development, profit and loss statement, dividend payments, and investments.

Why is the equity of Procept Biorobotics so important for investors?

The equity of Procept Biorobotics is important for investors as it is an indicator of the company's financial stability and provides investors with information on the amount of financial backing the company has in terms of obligations and future investments.

How does the number of employees at Procept Biorobotics influence the company?

The number of employees at Procept Biorobotics can directly impact the growth and performance of the company. A higher number of employees can lead to increased capacity and productivity, while a lower number of employees may result in reduced efficiency and limitations.

How has the number of employees at Procept Biorobotics evolved in recent years?

In recent years, the number of employees at Procept Biorobotics has changed by 0.

How many employees does Procept Biorobotics currently have?

Procept Biorobotics currently has 234 undefined employees.

Why is the number of employees important for investors of Procept Biorobotics?

The number of employees is important for investors of Procept Biorobotics as it is an indicator of the growth potential and performance of the company. It also provides information on how the company is able to manage and recruit its workforce.

What strategic measures can Procept Biorobotics take to change the number of employees?

To change the number of employees, Procept Biorobotics can take various measures such as adjusting compensation packages, improving working conditions, conducting recruitment campaigns, and promoting a positive corporate culture. It is important for the company to conduct a thorough assessment of its situation to determine the best strategic actions to change its number of employees.

How much dividend does Procept Biorobotics pay?

Over the past 12 months, Procept Biorobotics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Procept Biorobotics is expected to pay a dividend of 0 USD.

What is the dividend yield of Procept Biorobotics?

The current dividend yield of Procept Biorobotics is .

When does Procept Biorobotics pay dividends?

Procept Biorobotics pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Procept Biorobotics?

Procept Biorobotics paid dividends every year for the past 0 years.

What is the dividend of Procept Biorobotics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Procept Biorobotics located?

Procept Biorobotics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Procept Biorobotics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Procept Biorobotics from 12/17/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/17/2024.

When did Procept Biorobotics pay the last dividend?

The last dividend was paid out on 12/17/2024.

What was the dividend of Procept Biorobotics in the year 2023?

In the year 2023, Procept Biorobotics distributed 0 USD as dividends.

In which currency does Procept Biorobotics pay out the dividend?

The dividends of Procept Biorobotics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Procept Biorobotics

Our stock analysis for Procept Biorobotics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Procept Biorobotics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.